409 related articles for article (PubMed ID: 11274621)
21. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
[TBL] [Abstract][Full Text] [Related]
22. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
23. Varicella vaccine effectiveness during an outbreak in a partially vaccinated population in Spain.
Arnedo-Pena A; Puig-Barberà J; Aznar-Orenga MA; Ballester-Albiol M; Pardo-Serrano F; Bellido-Blasco JB; Romeu-García MA
Pediatr Infect Dis J; 2006 Sep; 25(9):774-8. PubMed ID: 16940832
[TBL] [Abstract][Full Text] [Related]
24. Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005.
Chaves SS; Zhang J; Civen R; Watson BM; Carbajal T; Perella D; Seward JF
J Infect Dis; 2008 Mar; 197 Suppl 2():S127-31. PubMed ID: 18419385
[TBL] [Abstract][Full Text] [Related]
25. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
[TBL] [Abstract][Full Text] [Related]
26. A review of the varicella vaccine in immunocompromised individuals.
Sartori AM
Int J Infect Dis; 2004 Sep; 8(5):259-70. PubMed ID: 15325594
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
28. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
[TBL] [Abstract][Full Text] [Related]
29. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
[TBL] [Abstract][Full Text] [Related]
30. Laboratory diagnosis and characteristics of breakthrough varicella in children.
Weinmann S; Chun C; Mullooly JP; Riedlinger K; Houston H; Loparev VN; Schmid DS; Seward JF
J Infect Dis; 2008 Mar; 197 Suppl 2():S132-8. PubMed ID: 18419386
[TBL] [Abstract][Full Text] [Related]
31. Varicella rates among unvaccinated and one-dose vaccinated healthy children in Izmir, Turkey.
Kurugol Z; Halicioglu O; Koc F; Koturoglu G; Aksit S
Int J Infect Dis; 2011 Jul; 15(7):e475-80. PubMed ID: 21592838
[TBL] [Abstract][Full Text] [Related]
32. Younger age at vaccination may increase risk of varicella vaccine failure.
Galil K; Fair E; Mountcastle N; Britz P; Seward J
J Infect Dis; 2002 Jul; 186(1):102-5. PubMed ID: 12089668
[TBL] [Abstract][Full Text] [Related]
33. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
[TBL] [Abstract][Full Text] [Related]
34. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
[TBL] [Abstract][Full Text] [Related]
35. Parental refusal of varicella vaccination and the associated risk of varicella infection in children.
Glanz JM; McClure DL; Magid DJ; Daley MF; France EK; Hambidge SJ
Arch Pediatr Adolesc Med; 2010 Jan; 164(1):66-70. PubMed ID: 20048244
[TBL] [Abstract][Full Text] [Related]
36. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
Wood SM; Shah SS; Steenhoff AP; Rutstein RM
Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
[TBL] [Abstract][Full Text] [Related]
37. Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study.
Tseng HF; Smith N; Marcy SM; Sy LS; Chao CR; Jacobsen SJ
Pediatr Infect Dis J; 2010 Mar; 29(3):205-8. PubMed ID: 19952977
[TBL] [Abstract][Full Text] [Related]
38. Varicella prevention in the United States: a review of successes and challenges.
Marin M; Meissner HC; Seward JF
Pediatrics; 2008 Sep; 122(3):e744-51. PubMed ID: 18762511
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
[TBL] [Abstract][Full Text] [Related]
40. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.
Hata A; Asanuma H; Rinki M; Sharp M; Wong RM; Blume K; Arvin AM
N Engl J Med; 2002 Jul; 347(1):26-34. PubMed ID: 12097537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
